Hodolic M - Search Results

1

Hodolic M, Fettich J, Banti E, Chondrogiannis S, Al-Nahhas A, Rubello D. Hodolic M, et al. In Vivo. 2010 Sep-Oct;24(5):771-4. In Vivo. 2010. PMID: 20952747 Review.

2

Factors influencing radioguided surgery of neuroendocrine tumours using 99mTc-ethylenediamine N,N'-diacetic acid/6-Hydrazinopyridine-3-carboxylic acid-D-Phe1-Tyr3-octreotide.

Hodolic M, Fettich J, Repse S, Peitl P, Lezaic L, Hojker S. Hodolic M, et al. Nucl Med Commun. 2008 Apr;29(4):311-7. doi: 10.1097/MNM.0b013e3282f2f99e. Nucl Med Commun. 2008. PMID: 18317293 Clinical Trial.

3

Reproducibility of 99mTc-mercaptoacetyltriglycine renography: population comparison.

Lezaic L, Hodolic M, Fettich J, Grmek M, Milcinski M. Lezaic L, et al. Among authors: hodolic m. Nucl Med Commun. 2008 Aug;29(8):695-704. doi: 10.1097/MNM.0b013e3283013d69. Nucl Med Commun. 2008. PMID: 18753822

4

Influence of tumour size and uptake of 99mTc-octreotide on radio-guided surgery for neuroendocrine tumors.

Hodolic M, Fettich J, Rubello D. Hodolic M, et al. Minerva Endocrinol. 2009 Jun;34(2):89-96. Minerva Endocrinol. 2009. PMID: 19471233

5

Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.

Naji M, Hodolic M, El-Refai S, Khan S, Marzola MC, Rubello D, Al-Nahhas A. Naji M, et al. Among authors: hodolic m. J Endocrinol Invest. 2010 Jan;33(1):54-60. doi: 10.1007/BF03346550. Epub 2009 Oct 9. J Endocrinol Invest. 2010. PMID: 19820296 Review.

6

Radioguided surgery and systemic radionuclide therapy of neuroendocrine tumours.

Hodolic M, Fettich J, Marzola MC, Tonini E, Al-Nahhas A, Rubello D. Hodolic M, et al. In Vivo. 2010 Jan-Feb;24(1):97-100. In Vivo. 2010. PMID: 20133983

7

Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.

Karunanithy N, Gordon F, Hodolic M, Al-Nahhas A, Wasan HS, Habib N, Tait NP. Karunanithy N, et al. Among authors: hodolic m. Cardiovasc Intervent Radiol. 2011 Apr;34(2):287-94. doi: 10.1007/s00270-010-9951-6. Epub 2010 Aug 11. Cardiovasc Intervent Radiol. 2011. PMID: 20700593

8

Unusual F-18 choline uptake in penile metastasis from prostate cancer.

Hodolič M, Fettich J, Cimitan M, Kragelj B, Goldsmith SJ. Hodolič M, et al. Clin Nucl Med. 2012 Apr;37(4):e89-90. doi: 10.1097/RLU.0b013e3182485311. Clin Nucl Med. 2012. PMID: 22391732 No abstract available.

9

Metastatic prostate cancer proven by 18F-FCH PET/CT staging scan in patient with normal PSA but high PSA doubling time.

Hodolič M, Maffione AM, Fettich J, Gubina B, Cimitan M, Rubello D. Hodolič M, et al. Clin Nucl Med. 2013 Sep;38(9):739-40. doi: 10.1097/RLU.0b013e31829b9d6b. Clin Nucl Med. 2013. PMID: 23816948

10

Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.

Cimitan M, Hodolič M, Maffione AM, Borsatti E, Urso C, Colletti PM, Rubello D. Cimitan M, et al. Among authors: hodolic m. Clin Nucl Med. 2013 Sep;38(9):752-4. doi: 10.1097/RLU.0b013e31829af8a6. Clin Nucl Med. 2013. PMID: 23856823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters